[Back to Breast Cancer
Index]
We are an 8-pathologist independent private practice
group in a very fine acute care general community hospital of over
300 beds having the busiest ER in S. C. and an over-100-doctor
Medical Services Organization (MSO) of employed physicians. We
have an excellent Breast Cancer program here but are not a breast
specialty hospital. That is, we are having to deal with a wide
variety of non-breast patient problems. So, dealing with breast
specimens has to work in with everything else. When lumpectomies
began in the mid-80s, we were challenged by Dr. Curtis McGown to
have a benign or malignant answer to the surgeons office by noon
the next day at the time of drain removal. We were probably able
to do this about 50% of the time; half the time, we felt that overnight
fixation was needed in order not to compromise detailed histological
evaluation. Fixation can be speeded up with initial inking and
fixation followed an hour or so later by serial slicing back into
fixative free or in cassettes and, when desired, fix in alcoholic
formalin for the faster penetration of the alcohol. Not being peer-recognized
breast experts, we have designed & refined
our reports to help clinicians and to "tell the story" to
patients and any subsequent knowledgeable layperson or physician,
local or at a distant location, who might impact on the patient's
situation. Reports sometimes include "photo reports" designed
to help both the clinical doctors and patient understand the situation
better...most often color-printed non-microscopic photos blended
with the written report & rarely a web-based report.
On bigger specimens, Hartmann's
fixative is a considerable help in locating malignant
foci (turns them white), as well as in helping to visualize
close margins with the naked eye. BUT, if breast marker
studies have not been done yet, you must get some
tumor and adjacent normal breast into formalin fixative as
formalin (10% NBF) or alcoholic formalin...theses two are the
internationally standardized fixatives for these semi-quantitative
IHC (or even FISH or CISH) determinations and for the genomic studies.
Our rapid turn around time is focused primarily on core biopsies,
IHC (done on site) markers usually taking another day. Path
reports are in prose (NOT synoptic) and include gross details,
micro details, and diagnostic parameters of importance to our
clinicians. We do use templates (macros) to help us be sure
to address all factors. If, for example, I think it is a cancer
or initial slides show cancer, I dictate to the transcriptionist
something like, "On case L05-444, Mrs. Jones, micro is
standard template 'mbrca' and diagnosis is template 'B4'." Then
I can view those "macros" within the working copy
of the path report and be sure that all desired parameters
are addressed (as I study the case).
-
Receipt of any breast specimen: the surgical
pathology clerical assistant (person logging the specimen in)
checks the pathology information system for any previous anatomic
pathology reports or breast conference or case notes & prints
them off for the pathologist and may also check the hospital
information system (HIS) for mammogram, ultrasound, or MRI
reports that might pertain to the case. This is done to help
assure that the pathologist has "case context" to
work with when grossing the specimen in. In rare instances,
we may have to review the specimen with the surgeon or radiologist
prior to dissection.
- dealing with cytology specimens: we try to turn around
FNA diagnoses by FAX or phone same day; aspiration fluid cytologies
from radiology come to us with a standard sheet [here] filled
out to give us enough clinical information such that we pathologists
are better enabled to issue a more decisive report as to negativity
or positivity and avoid issuing reports and overusing such CYA
terminology as "a few atypical cells noted & can't rule
out malignancy".
- handling core biopsies:
-
path report, gross: we have a standard
gross paragraph that, among other things, notes that
radiologist gets cores rapidly into formalin and details
the specimen according to whether supposedly has calcifications
or not.
-
fixation: provided the cores get
at least two hours formalin fixation prior to being placed
on the tissue processor, we have routine H&E sections
of cores ready by 7:30AM the next business day following
the biopsy day.
-
"yellow breast biopsy FAX sheet": coming
from Breast Center with core specimens is a standard
information sheet [here] that tells us the "gross
pathology" of the tumor, physical exam information
as to location, etc., about whether a "calcifications" case
or "density" case, and what the radiologist's
differential diagnosis is. As soon as diagnosis is made
next morning from H&E slides, a note is made onto
the yellow FAX sheet as to diagnosis and concordance
or discordance & sheet is FAXed to the Breast Center & they make
contacts to patient and referring doctor. We make sure
referring doctor, breast center, breast health services,
and surgeon get path report copies.
-
handling sentinel lymph nodes: If our
surgeons find the sentinel node and it looks "suspicious" to
them and the situation is OK to do an axillary dissection,
he/she may send the node for frozen section...we do not do
routine SLN frozen sections. In such a case, the pathologist
will record node features, serially section it and chose any
slice with any abnormal-looking area (or, if no area be looking
abnormal, just chose a cross-section). Pathologist might decide
to also do a cut surface touch prep additionally or even alternatively
to a frozen section. At any rate, every attempt is made to
conserve node for permanent, "intense protocol" processing
should the FS be benign. [surgeon's method]
[intense histological
assessment, why & how]
- processing lymph node dissections:...the patient's life
depends on us!
-
you must find all nodes: who
dissects & how
-
you must detect cancer if is in any
node: intense processing using agar & agar depth
sticks to assure step-cutting
- processing diagnostic lumpectomies:......weigh,
measure, & describe.
- surgical margins: by visual exam and palpation
and exam of any accompanying specimen radiograph, try to
see if there is a close or positive margin & mark that
spot with a non-black dye; then ink margins with India
ink (black) & briefly dip in vinegar (dilute acetic
acid) to seal the ink to the surgical margin surfaces,
and then put into fixative. Have IHC markers already been
done (see above)?...if not, get some tumor & benign
glandular tissue into 10% NBF. Place other into proper
fixative (possibly needing overnight fixation); later select
blocks, process, and sign out.
- written grossing notes: sometimes use "scratch
paper" to sketch the specimen & key notes on it
as to where blocks came from (we don't necessarily submit
all of a lumpectomy for microscopic exam).
- FAX diagnosis: at time of dictation, we write
diagnosis on a FAX sheet for each surgery group [example] & FAX
note to his/her office. Case updates can also be additionally
FAXed out of CoPath.
- processing conservative cancer treatment lumpectomies:......weigh,
measure, & describe.
- surgical margins: by visual exam and palpation
and exam of any accompanying specimen radiograph try to
see if there is a close or positive margin & mark the
spot with a non-black dye; then ink margins with India
ink (black) & briefly dip in vinegar (dilute acetic
acid) to seal the ink to the surgical margin surfaces.
Have IHC markers already been done (see above)?...if not,
get some tumor & benign glandular tissue into 10% NBF. Place
into proper fixative (possibly needing overnight fixation);
later select blocks, process, and sign out.
- written grossing notes: sometimes use "scratch
paper" to sketch the specimen & key notes on it
as to where blocks came from (we don't necessarily submit
all of a lumpectomy for microscopic exam).
- FAX diagnosis: at time of dictation, we write
diagnosis on a FAX sheet for each surgery group & FAX
note to his/her office. Case updates can also be additionally
FAXed out of CoPath.
- processing mastectomies:
-
block selection: The above report
copies are used to see how extensive the exam must be.
We look for multifocal lesions, skin/nipple involvement,
and closeness & negativity/positivity of surgical
margins. Have IHC markers already been done (see above)?...if
not, get some tumor & benign glandular tissue into
10% NBF. I almost always fix mastectomies (I usually
make some incomplete cross-sections to aid fixation)
with Hartmann's and at least overnight & select blocks,
process, and sign out.
- written grossing notes: sometimes use "scratch
paper" to sketch the specimen & key notes on it
as to where blocks came from.
- Special studies: we do a wide variety of IHC stains
on campus; FISH studies for such as HER-2 and any DNA ploidy
studies (10% NBF fixation required) are performed at PhenoPath
Labs in Seattle. The OncotypeDX
genomic studies by TAQMAN technique are performed at Genomic
Health Lab in Redwood City, Calif. One of our pathologists selects
the appropriate block to be sent for such tests.
- multidisciplinary conference:
- presenting pathology: In that most clinicians
are unequipped to appreciate fine points of histology & cytology,
we only actually show "slides" to actually make
a point...often to illustrate the attention to detail needed
for precision evaluation in breast pathology.
- getting information: Just as a clinician needs
history and physical exam and ancillary information to
properly work with a patient, the patient is often best
served when we approach a breast specimen armed with information.
The conference is often the only place to get really accurate
information as to potential maximum size of lesion, exact
lesion location, and maybe another detail unique to that
case.
- in-house conference notes: Immediately following
conference, pathologist coordinator dictates "heads
up" or FYI notes into the pathology LIS. And, since
these do not appear in the patient's global medical record,
note might say such as, "Watch out, tumor close to
chest wall so closest lumpectomy margin is likely that
chest wall margin."...or, "Watch out, imaging
thinks there could be two tumors vs. a dumbbell-shaped
single tumor."...being sure of which might profoundly
affect the tumor size for TNM staging.
- processing reduction mammoplasties: Since about 1%
of such cases harbor an occult cancer, we use Hartmann's fixative
as a "subgrossing" process in that it causes foci rich
in nuclei to stand out as white foci or nodules within an otherwise
non-descript fibrofatty stromal background. Even this process
can miss lobular; so, careful inspection visually and by palpation
is also needed. The typical case gets two cassettes per breast.
(posted 22 April 2005;
latest addition 21 July 2005) |